Transcriptional regulation of bone sialoprotein gene by Porphyromonas gingivalis lipopolysaccharide

Journal of Cellular Biochemistry

Volumn 110, Issue 4, 2010, Pages 823-833

  Li, Xinyue ^a,b   Kato, Naoko ^a   Mezawa, Masaru ^a   Li, Zhengyang ^a,b   Wang, Zhitao ^a,b   Yang, Li ^a,b   Sasaki, Yoko ^a   Kaneko, Takashi ^c   Takai, Hideki ^a   Yoshimura, Atsutoshi ^c   Ogata, Yorimasa ^a  

^a NIHON UNIVERSITY   (Japan)

^b TIANJIN STOMATOLOGICAL HOSPITAL   (China)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Bone formation; Bone sialoprotein; Lipopolysaccharide; Osteoblasts; Porphyromonas gingivalis; Transcription

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ACETYLCYSTEINE; BACTERIUM LIPOPOLYSACCHARIDE; BONE SIALOPROTEIN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FIBROBLAST GROWTH FACTOR 2; HERBIMYCIN A; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; SMAD1 PROTEIN; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR JUND; TRANSCRIPTION FACTOR RUNX2; IBSP PROTEIN, RAT; LIPOPOLYSACCHARIDE; PRIMER DNA; SIALOGLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RAT; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; GENETICS; METABOLISM; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; REGULATORY SEQUENCE; TUMOR CELL LINE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PORPHYROMONAS GINGIVALIS; RATTUS;

ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; INTEGRIN-BINDING SIALOPROTEIN; LIPOPOLYSACCHARIDES; POLYMERASE CHAIN REACTION; PORPHYROMONAS GINGIVALIS; RATS; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; SIALOGLYCOPROTEINS; TRANSCRIPTION, GENETIC;

EID: 77954118509     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22594     Document Type: Article

References (47)

1. Antonicelli F, Brown D, Parmentier M, Drost EM, Hirani N, Rahman I, Donaldson K, MacNee W. 2004. Regulation of LPS-mediated inflammation in vivo and in vitro by the thiol antioxidant Nacystelyn. Am J Physiol Lung Cell Mol Physiol 286:L1319-L1327.
2. Araki S, Mezawa M, Sasaki Y, Yang L, Li Z, Takai H, Nakayama Y, Ogata Y. 2009. Parathyroid hormone regulation of the human bone sialoprotein gene transcription is mediated through two cAMP response elements. J Cell Biochem 106:618-625.
3. Cip1 expression. J Biol Chem 277:13761-13770.
4. Benson MD, Aubin JE, Xiao G, Thomas PE, Franceschi RT. 1999. Cloning of a 2.5 kb murine bone sialoprotein promoter fragment and functional analysis of putative Osf2 binding sites. J Bone Miner Res 14:396-405. (Pubitemid 29106716)
5. Benson MD, Bargeon JL, Xiao G, Thomas PE, Kim A, Cui Y, Franceschi RT. 2000. Identification of a homeodomain binding element in the bone sialoprotein gene promoter that is required for its osteoblast selective expression. J Biol Chem 275:13907-13917.
6. Chen J, Shapiro HS, Sodek J. 1992. Developmental expression of bone sialoprotein mRNA in rat mineralized connective tissues. J Bone Miner Res 7:987-997.
7. Cohn EF, Nathan C, Radzioch D, Yu H, Xiang Z, Ding A. 2006. Abrupt expression of TLR4 in TLR4-deficient Macrophages imposes a selective disadvantage: Genetic evidence for TLR4-dependent responses to endogenous, nonmicrobial stimuli. J Immunol 176:1185-1194. (Pubitemid 43099722)
8. Darveau RP, Tanner A, Page RC. 1997. The microbial challenge in periodontitis. Peridontol 2000(14):12-32.
9. Darveau RP, Arbabi S, Garcia I, Bainbridge B, Maier RV. 2002. Porphyromonas gingivalis lipopolysaccharide is both agonist and antagonist for p38 mitogen-activated protein kinase activation. Infect Immun 70:1867-1873.
10. Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, Howald WN, Wat SS, Hajjar AM. 2004. Porphyromonas gingivalis lipopolysaccharide contains multiple Lipid A species that functionally interact with both Tolllike receptors 2 and 4. Infect Immun 72:5041-5051.
11. David MD, Cochrane CL, Duncan SK, Schrader JW. 2005. Pure lipopolysaccharide or synthetic Lipid A induces activation of p21Ras in primary macrophages through a pathway dependent on Src family kinases and PI3K. J Immunol 175:8236-8241.
12. Fukusaki T, Ohara N, Hara Y, Yoshimura A, Yoshiura K. 2007. Evidence for association between a toll-like receptor 4 gene polymorphism and moderate/ severe periodontitis in the Japanese population. J Periodontal Res 42:541-545.
13. Ganss B, Kim RH, Sodek J. 1999. Bone sialoprotein. Crit Rev Oral Biol Med 10:79-98.
14. Hunter GK, Goldberg HA. 1993. Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci USA 90:8562-8565.
15. Jheon A, Bansal AK, Zhu B, Ganss B, Cheifetz S, Sodek J. 2009. Characterisation of the constitutive over-expression of AJ18 in a novel rat stromal bone marrow cell line (D8-SBMC). Arch Oral Biol 54:705-716.
16. Jiang Y, Mehta CK, Hsu TY, Alsulaimani FFH. 2002. Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. Infect Immun 70:3143-3148.
17. Kadono H, Kido JI, Kataoka M, Yamauchi N, Nagata T. 1999. Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect Immun 67:2841-2846. (Pubitemid 29244698)
18. Kato N, Nakayama Y, Nakajima Y, Samoto H, Saito R, Yamanouchi F, Masunaga H, Shimizu E, Ogata Y. 2006. Regulation of bone sialoprotein (BSP) gene transcription by lipopolysaccharide. J Cell Biochem 97:368-379.
19. Kim RH, Sodek J. 1999. Transcription of the bone sialoprotein gene is stimulated by v-Src acting through an inverted CCAAT box. Cancer Res 59:565-571.
20. Kim RH, Shapiro HS, Li JJ, Wrana JL, Sodek J. 1994. Characterization of the human bone sialoprotein (BSP) gene and its promoter sequence. Matrix Biol 14:31-40.
21. Kim RH, Li JJ, Ogata Y, Yamauchi M, Freedman LP, Sodek J. 1996. Identification of a vitamin D3-response element that overlaps a unique inverted TATA box in the rat bone sialoprotein gene. Biochem J 318:219-226.
22. Kirkwood KL, Li F, Rogers JE, Otremba J, Coatney DD, Kreider JM, D'Silva NJ, Chakravarty S, Dugar S, Higgins LS, Protter AA, Medicherla S. 2007. A p38α selective mitogen activated protein kinase inhibitor prevents periodontal bone loss. J Pharmacol Exp Ther 320:56-63.
23. Kiyoshima T, Yamauchi M, Wong C, Jheon A, Ganss B, Sodek J. 2002. An L1 element disrupts human bone sialoprotein promoter: Lack of tissue-specific regulation by distalless5 (Dlx5) and runt homeodomain protein2 (Runx2)/ core binding factor a1 (Cbfa1) elements. Gene 299:205-217.
24. Kocgozlu L, Elkaim R, Tenenbaum H, Werner S. 2009. Variable cell responses to P. gingivalis lipopolysaccharide. J Dent Res 88:741-745.
25. Li JJ, Sodek J. 1993. Cloning and characterization of the rat bone sialoprotein gene promoter. Biochem J 289:625-629. (Pubitemid 23074940)
26. Li JJ, Kim RH, Sodek J. 1995. An inverted TATA box directs downstream transcription of the bone sialoprotein gene. Biochem J 310:33-40.
27. Lin FY, Chen YH, Tasi JS, Chen JW, Yang TL, Wang HJ, Li CY, Chen YL, Lin SJ. 2006. Endotoxin induces Toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways. Arterioscler Thromb Vasc Biol 26:2630-2637.
28. Malaval L, Wada-Guéye NM, Boudiffa M, Fei J, Zirngibl R, Chen F, Laroche N, Roux J, Burt-Pichat B, Duboeuf F, Boivin G, Jurdic P, Lafage-Proust M, Amédée J, Vico L, Rossant J, Aubin JE. 2008. Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med 205: 1145-1153.
29. Mezawa M, Araki S, Takai H, Sasaki Y, Wang S, Li X, Kim DS, Nakayama Y, Ogata Y. 2009. Regulation of human bone sialoprotein gene transcription by platelet-derived growth factor-BB. Gene 435:80-87.
30. Nakayama Y, Nakajima Y, Kato N, Takai H, Kim DS, Arai M, Mezawa M, Araki S, Sodek J, Ogata Y. 2006. Insulin-like growth factor-I increases bone sialoprotein (BSP) expression through fibroblast growth factor-2 response element and homeodomain protein-binding site in the proximal promoter of the BSP gene. J Cell Physiol 208:326-335.
31. Nemoto E, Darveau RP, Foster BL, Nogueira-Filho GR, Somerrman MJ. 2006. Regulation of cementoblast function by P. gingivalis lipopolysaccharide via TLR2. J Dent Res 85:733-738.
32. Ogata Y. 2008. Bone sialoprotein and its transcriptional regulatory mechanism. J Periodontal Res 43:127-135.
33. Ogata Y, Yamauchi M, Kim RH, Li JJ, Freedman LP, Sodek J. 1995. Glucocorticoid regulation of bone sialoprotein (BSP) gene expression: Identification of a glucocorticoid response element in the bone sialoprotein gene promoter. Eur J Biochem 230:183-192.
34. Ogata Y, Niisato N, Furuyama S, Cheifetz S, Kim RH, Sugiya H, Sodek J. 1997. Transforming growth factor-b regulation of bone sialoprotein gene transcription: Identification of a TGF-b activation element in the rat BSP gene promoter. J Cell Biochem 65:501-512.
35. Ogata Y, Nakao S, Kim RH, Li JJ, Furuyama S, Sugiya H, Sodek J. 2000. Parathyroid hormone regulation of bone sialoprotein (BSP) gene transcription is mediated through a pituitary specific transcription factor-1 (Pit-1) motif in the rat BSP gene promoter. Matrix Biol 19:395-407.
36. Peng T, Lu X, Feng Q. 2005. Pivotal role of gp91phox-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor expression and myocardial depression. Circulation 111:1637-1644.
37. Samoto H, Shimizu E, Matsuda-Honjo Y, Saito R, Nakao S, Yamazaki M, Furuyama S, Sugiya H, Sodek J, Ogata Y. 2003. Prostaglandin E2 stimulates bone sialoprotein (BSP) expression through cAMP and FGF2 response elements in the proximal promoter of the rat BSP gene. J Biol Chem 278:28659-28667.
38. Shimizu E, Ogata Y. 2002. Activation of bone sialoprotein gene transcription by flavonoids is mediated through an inverted CCAAT box in ROS 17/2.8 cells. J Cell Biochem 86:35-44.
39. Shimizu E, Nakayama Y, Nakajima Y, Kato N, Takai H, Kim DS, Arai M, Saito R, Sodek J, Ogata Y. 2006. Fibroblast growth factor 2 and cyclic AMP synergistically regulate bone sialoprotein gene expression. Bone 39:42-52.
40. Shimizu-Sasaki E, Yamazaki M, Furuyama S, Sugiya H, Sodek J, Ogata Y. 2001. Identification of a novel response element in the rat bone sialoprotein (BSP) gene promoter that mediates constitutive and fibroblast growth factor 2-induced expression of BSP. J Biol Chem 276:5459-5466.
41. Socransky SS, Haffajee AD. 1992. The bacterial etiology of destructive periodontal disease: Current concepts. J Periodontol 63:322-331.
42. Takai H, Araki S, Mezawa M, Kim DS, Li X, Yang L, Li Z, Wang Z, Nakayama Y, Ogata Y. 2008. AP1 binding site is another target of FGF2 regulation of bone sialoprotein gene transcription. Gene 410:97-104.
43. Waltregny D, Bellahcène A, Leval XD, Florkin B, Weidle U, Castronovo V. 2000. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers. J Bone Miner Res 15:834-843.
44. Wang PL, Ohura K. 2002. Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts -CD14 and Toll-like receptors. Crit Rev Oral Biol Med 13:132-142. (Pubitemid 34791214)
45. Wang H, Xu DX, Lu JW, Zhao L, Zhang C, Wei W. 2007. N-Acetylcysteine attenuates lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice. Acta Pharmacol Sin 28:1803-1809. (Pubitemid 350029328)
46. Yamauchi M, Ogata Y, Kim RH, Li JJ, Freedman LP, Sodek J. 1996. AP-1 regulation of the rat bone sialoprotein gene transcription is mediated through a TPA response element within a glucocorticoid response unit in the gene promoter. Matrix Biol 15:119-130.
47. Yoshimura A, Kaneko T, Kato Y, Golenbock DT, Hara Y. 2002. Lipopoly-saccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human toll-like receptor 4. Infect Immun 70:218-225.